These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12092169)

  • 1. [Neurogenetics in Parkinson's disease].
    Stefanache F; Hodorog D; Cuciureanu D
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(3):431-7. PubMed ID: 12092169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Parkinson disease: monogenic forms and genetic susceptibility factors].
    Brice A
    Pathol Biol (Paris); 1998 Nov; 46(9):710-2. PubMed ID: 9885826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease: piecing together a genetic jigsaw.
    Dekker MC; Bonifati V; van Duijn CM
    Brain; 2003 Aug; 126(Pt 8):1722-33. PubMed ID: 12805097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease.
    Mamah CE; Lesnick TG; Lincoln SJ; Strain KJ; de Andrade M; Bower JH; Ahlskog JE; Rocca WA; Farrer MJ; Maraganore DM
    Ann Neurol; 2005 Mar; 57(3):439-43. PubMed ID: 15732111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
    Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R
    Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
    Mellick GD; Maraganore DM; Silburn PA
    Neurosci Lett; 2005 Feb; 375(2):112-6. PubMed ID: 15670652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency of alpha-synuclein mutations in familial Parkinson's disease.
    Farrer M; Wavrant-De Vrieze F; Crook R; Boles L; Perez-Tur J; Hardy J; Johnson WG; Steele J; Maraganore D; Gwinn K; Lynch T
    Ann Neurol; 1998 Mar; 43(3):394-7. PubMed ID: 9506559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple regions of alpha-synuclein are associated with Parkinson's disease.
    Mueller JC; Fuchs J; Hofer A; Zimprich A; Lichtner P; Illig T; Berg D; Wüllner U; Meitinger T; Gasser T
    Ann Neurol; 2005 Apr; 57(4):535-41. PubMed ID: 15786467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene dosage and pathogenesis of Parkinson's disease.
    Eriksen JL; Przedborski S; Petrucelli L
    Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosology of Parkinson's disease: looking for the way out of a quagmire.
    Forman MS; Lee VM; Trojanowski JQ
    Neuron; 2005 Aug; 47(4):479-82. PubMed ID: 16102530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Synuclein locus triplication causes Parkinson's disease.
    Singleton AB; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson MR; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K
    Science; 2003 Oct; 302(5646):841. PubMed ID: 14593171
    [No Abstract]   [Full Text] [Related]  

  • 13. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
    Krüger R; Kuhn W; Müller T; Woitalla D; Graeber M; Kösel S; Przuntek H; Epplen JT; Schöls L; Riess O
    Nat Genet; 1998 Feb; 18(2):106-8. PubMed ID: 9462735
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene-environment interactions in sporadic Parkinson's disease.
    Benmoyal-Segal L; Soreq H
    J Neurochem; 2006 Jun; 97(6):1740-55. PubMed ID: 16805780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Synuclein gene and Parkinson's disease. The French Parkinson's Disease Study Group.
    Science; 1998 Feb; 279(5354):1116-7. PubMed ID: 9508681
    [No Abstract]   [Full Text] [Related]  

  • 16. alpha-Synuclein promoter confers susceptibility to Parkinson's disease.
    Pals P; Lincoln S; Manning J; Heckman M; Skipper L; Hulihan M; Van den Broeck M; De Pooter T; Cras P; Crook J; Van Broeckhoven C; Farrer MJ
    Ann Neurol; 2004 Oct; 56(4):591-5. PubMed ID: 15455394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [alpha-Synuclein and familial Parkinson's disease].
    Iwatsubo T
    No To Shinkei; 1999 Jun; 51(6):481-6. PubMed ID: 10423749
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetics of Parkinson's disease.
    Lynch T; Farrer M; Hutton M; Hardy J
    Science; 1997 Nov; 278(5341):1212-3. PubMed ID: 9411743
    [No Abstract]   [Full Text] [Related]  

  • 19. A Drosophila model of Parkinson's disease.
    Feany MB; Bender WW
    Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.